Dr. Ciaran Byrne:

Yes, we monitor in that way. That is exactly the point. We launch the schemes, take information and look at what happened. Did what we want happen? Did enough of it happen? Do we need to tweak the offering or focus on a different one? Yes, absolutely, that was a great point.

On EPBD, we are definitely involved at a European level. I might ask my colleague, Mr. O’Mahony, to come in on that point.